Successful T cell engineering with gene scissors
The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as effective as natural T cells and have been only been of limited clinical value. Using the new CRISPR-Cas9 gene editing tool, a team at the Technical University of Munich (TUM) has now engineered T cells that are very similar to physiological immune cells.
There are two forms of T cell therapy: either a recipient receives cells from a donor, or the recipient’s own T cells are removed, genetically reprogrammed in a laboratory and unleashed against an infection or tumor in the body. While the first method has proven to be successful in clinical models, reprogramming T cells is still beset with problems.
The team led by Professor Dirk Busch, Director of the Institute for Medical Microbiology, Immunology and Hygiene at the TUM, has generated modified T cells for the first time that are very similar to their natural counterparts and could solve some of those problems. To do so, they utilized the new CRISPR-Cas9 gene scissors, which can be used to snip out and replace targeted segments of the genome.
Both the conventional methods and the new method target the key homing instrument of T cells, known as the T cell receptor. The receptor, residing on the cell’s surface, recognizes specific antigens associated with pathogens or tumor cells, which the T cell is then able to attack. Each receptor is made up of two molecular chains that are linked together. The genetic information for the chains can be genetically modified to produce new receptors that are able to recognize any desired antigen. In this way, it is possible to reprogram T cells.
Targeted exchange using the CRISPR-Cas9 gene scissors
The problem with conventional methods is that the genetic information for the new receptors is randomly inserted into the genome. This means that T cells are produced with both new and old receptors or with receptors having one old and one new chain. As a result, the cells do not function as effectively as physiological T cells and are also controlled differently. Moreover, there is a danger that the mixed chains could trigger dangerous side effects (Graft-versus-Host Disease, GvHD).
“Using the CRISPR method, we’ve been able to completely replace the natural receptors with new ones, because we’re able to insert them into the very same location in the genome. In addition, we’ve replaced the information for both chains so that there are no longer any mixed receptors,” explains Kilian Schober, who is a lead author of the new study along with his colleague Thomas Müller.
Thomas Müller explains the advantages of the modified T cells: “They’re much more similar to physiological T cells, yet they can be changed flexibly. They’re controlled like physiological cells and have the same structure, but are capable of being genetically modified.“ The scientists have demonstrated in a cell culture model that T cells modified in this way behave nearly exactly like their natural counterparts.
“Another advantage is that the new method allows multiple T cells to be modified simultaneously so that they’re able to recognize different targets and can be used in combination. This is especially interesting for cancer therapy, because tumors are highly heterogeneous,” Dirk Busch adds. In the future, the team plans to investigate the new cells and their properties in preclinical mouse models, an important step in preparing for clinical trials with humans.
Learn more: Successful T cell engineering with gene scissors
The Latest on: CRISPR-Cas9 gene scissors
via Google News
The Latest on: CRISPR-Cas9 gene scissors
- Chinese scientists develop gene therapy that could delay ageingon January 20, 2021 at 8:00 am
A new gene therapy has been shown to reverse some of the effects of ageing in mice and extend their lifespans by up to a quarter. Chinese researchers used CRISPR-Cas9, a powerful gene-editing tool, to ...
- Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switchon January 19, 2021 at 2:45 pm
Cas9 systems avoid causing autoimmunity in bacteria when they complex with a natural single-guide RNA that is a long-form tracrRNA that targets a Cas9 promoter.
- Gene-cutting system may play second role as a genetic dimmer switchon January 19, 2021 at 7:54 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9 -- as a ...
- CRISPR technology shown to dial down gene activity in bacteriaon January 19, 2021 at 7:31 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9—as a genetic ...
- Gene-editing 'scissor' tool may also be a 'dimmer switch'on January 19, 2021 at 6:03 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9 -- as a genet ...
- Reaping benefits: ‘Scissors’ snip off bad genes in plantson January 17, 2021 at 10:13 am
Gene (genome) editing techniques, being developed from the 1990s, stayed largely out of the limelight until a pair of “molecular scissors” called CRISPR-Cas9 was discovered by two women ...
- Emmanuelle Charpentier And Jennifer Doudna Sharpened Mother Nature’s Genetic Scissors And Won The Nobel For Iton January 16, 2021 at 4:00 pm
Since Emmanuelle and Jennifer published their 2012 paper on CRISPR/Cas9, researchers have used these genetic scissors to create drought-resistant plants and look for new gene-based cancer therapies.
- 7 CRISPR Stocks for the Future of Medicineon January 15, 2021 at 11:06 pm
Doudna and Charpentier invented a pair of “scissors” – called CRISPR-Cas9 systems – to cut specific ... with a robust and mature gene editing therapy pipeline focused on curing sickle ...
- 7 CRISPR Stocks for the Future of Medicineon January 15, 2021 at 3:12 pm
Doudna and Charpentier noted a naturally occurring genome editing system in bacteria, wherein bacteria capture snippets of DNA from invading viruses and create new DNA segments called CRISPR arrays ...
- With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edgeon January 14, 2021 at 11:54 pm
Gene editing is advancing so quickly that next-generation technologies are already on the heels of Crispr-Cas9, including a ... to direct the Cas molecular scissors to almost any genomic address.
via Bing News